RE:RE:RE:RE:Huh? Someone in the States will get burned.
below is the written commentary that went along with John's discussion on BNN: Concordia Health is a Canadian pharmaceutical company that owns and markets a variety of drugs. It has been painted with the same brush as another Canadian pharmaceutical company, but is not plagued with any of the same issues. The company has recently announced the formation of a committee to review strategic alternatives, and rumors have been swirling about a potential buyout, but independent of all the noise, the company is still well run, in good financial shape, and has many profitable products in the pipeline. They recently acquired Amdipharm Mercury, which provided them with both a large portfolio of pipeline products, diversification, and exposure to the international market. Despite having to increase leverage to close the deal, the business continues to generate strong free cash flow which will enable them to pay down debt in a timely manner. It is trading extremely attractively right now relative to both the market and its comparables in the sector and we believe that it presents a compelling opportunity.